Articles

TLR3 agonism augments CD47 inhibition in acute myeloid leukemia

Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; Program in Cancer Biology
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; Center for Immunobiology; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
Vol. 109 No. 7 (2024): July, 2024 https://doi.org/10.3324/haematol.2023.283850